Showing results (341-350 of 376) with videos related to
Sort By:
Pageof 38
AIDS (London, England)|July 7, 2026
CD4+ cell count trends after common cancers in people with HIV: a multicohort collaborationAlisa Timiryasova, Lauren Greenberg, Pere Domingo, et al.Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|June 10, 2018
Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adultsJosé Antonio Pérez-Molina, Esteban Martínez, Antonio Javier Blasco, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2009
Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP studyJosep Mallolas, Daniel Podzamczer, Ana Milinkovic, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2018
Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 StudyJosé M Gatell, Lambert Assoumou, Graeme Moyle, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 14, 2009
Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed PatientsDaniel Podzamczer, Montserrat Olmo, Jose Sanz, et al.Open Forum Infectious Diseases|July 17, 2024
Discrimination of the Veterans Aging Cohort Study Index 2.0 for Predicting Cause-specific Mortality Among Persons With HIV in Europe and North AmericaJulie Ambia, Suzanne M Ingle, Kathleen McGinnis, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational studyCristina Mussini, Patrizio Pezzotti, José M Miró, et al.Gaceta Sanitaria|February 20, 2007
[Delayed diagnosis of HIV infection in the Spanish VACH cohort [1997-2002]]Ramón Teira Cobo, Ignacio Suárez Lozano, Juan Miguel Santamaría Jáuregui, et al.Diagnostic Microbiology and Infectious Disease|June 17, 2008
Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortalityMíriam J Alvarez-Martínez, Asunción Moreno, José M Miró, et al.Trials|November 16, 2021
Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trialBerta Grau-Pujol, Daniel Camprubí-Ferrer, Helena Marti-Soler, et al.Pageof 38